Obtaining molecular genotyping results before first-line treatment resulted in better outcomes for patients with non-small cell lung cancer, an expert explained. A recent study showed that undergoing ...

Consent is an important consideration if introducing testing. A patient expert highlighted that people who have had a stroke often have severe cognitive impairment, may have difficulty with their ...

The observational extended study of the previously reported 12-month randomized TAILOR-PCI trial shows genotype-guided antiplatelet therapy after percutaneous coronary intervention (PCI) did not ...

Clinicians should offer a genetic test to people who have had an ischaemic stroke or transient ischaemic attack to determine whether they can be treated with the drug clopidogrel to reduce the risk of ...

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to aid in the design, validation ...

A genotype-guided strategy for deciding on antiplatelet agents after PCI does not lead to improvements in long-term ischemic events, according to extended follow-up from TAILOR-PCI. The results are in ...

A leading testing expert says DNA genotype testing is revealing how most of us have a little Neanderthal in our blood, and how our unique DNA sequence can reveal our origins and track our ancestors' ...

Screening for colorectal cancer in France: Third edition of the EDIFICE survey. Background: Irinotecan is metabolized primarily in the liver by the carboxylesterase enzyme to the SN-38 active ...

FDA this week approved its first genotyping test for patients with hepatitis C virus (HCV), Abbott’s RealTime HCV Genotype II. The test can differentiate genotypes ...

BD Onclarity™ HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45 FRANKLIN LAKES, N.J., July 22, 2020 /PRNewswire/ -- BD (Becton, Dickinson ...